Clin2
NCT05540197Possibly a fitEnrolling by invitation

Test whether arginine affects early results after islet transplant

Islets of Langerhans TransplantationDiabetes MellitusChronic Pancreatitis

Part of Digestive system, Hormones & metabolism clinical trials.

This trial studies whether taking arginine changes how well people do soon after an islet transplant. It may help improve early outcomes and guide care for people who are getting ready for this treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
16 years and older
Study type
Observational

Who can take part

  • You are age 16 or older
  • You are currently on the LUMC waiting list for an islet transplant (either from a donor or your own cells)
  • You can and are willing to use a flash glucose monitoring (FGM) device for 2 weeks before the transplant
  • You are not pregnant (or will not be during the study)
  • You have no known allergy or strong reaction to arginine

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05287737Enrolling by invitation
After TPIAT and blood-sugar sensor study

This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.

Leiden, South Holland
NCT03097185Recruiting
Checking how well transplanted islet cells work in chronic pancreatitis

This study looks at how well a treatment works after islet cell transplantation done for people with long-term (chronic) pancreatitis. It may help doctors better understand graft (transplant) function and how to choose the best approach and follow-up.

Dallas, Texas
NCT06095492Recruiting
Comparing diabetes drugs after kidney transplant

This trial tests two diabetes medications, empagliflozin and linagliptin, to see which one works better for controlling blood sugar, protecting kidney function, and improving body composition in people who have had a kidney transplant and have diabetes.

Gurgaon, Haryana
NCT03746769Recruiting· Phase 1/Phase 2
Testing gastrin to improve results of islet cell transplant

This trial looks at whether adding gastrin can improve outcomes after an islet cell transplant for people with type 1 diabetes. It may help some participants achieve better blood sugar control, but it also requires close follow-up and immune-suppressing medications to protect the new cells.

Duarte, California
NCT06686069Not yet recruiting
L-arginine supplement for blood sugar and metabolic health

This trial tests whether taking an L-arginine supplement (a type of amino acid) each day can help improve how your body uses insulin and protects the cells that make insulin. It may be an option if you have prediabetes or metabolic syndrome and are looking for a simple daily supplement to support your metabolic health.

NCT07118475Enrolling by invitation· Early Phase 1
Islet transplant for type 2 diabetes

This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.

Shanghai

Hear when a new Islets of Langerhans Transplantation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.